Ingevity Corp Announces Executive and Board Changes

Ticker: NGVT · Form: 8-K · Filed: 2024-07-01T00:00:00.000Z

Sentiment: neutral

Topics: leadership-change, board-of-directors, executive-appointments

Related Tickers: NGVT

TL;DR

Ingevity's board and exec team are shuffling; new faces and departures reported.

AI Summary

Ingevity Corporation announced on June 26, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers. Specific names and dollar amounts related to these changes were not detailed in the provided excerpt.

Why It Matters

Changes in leadership and board composition can signal shifts in company strategy, governance, and future performance.

Risk Assessment

Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and operational direction.

Key Players & Entities

FAQ

What specific roles have been affected by the departures and appointments?

The filing indicates departures of certain officers and directors, and the election of new directors, but does not specify the exact roles in the provided excerpt.

When did the reported changes take effect?

The earliest event reported is dated June 26, 2024.

Are there any details on new compensatory arrangements for officers?

The filing mentions updates to compensatory arrangements of certain officers, but specific details are not included in the excerpt.

What is Ingevity Corporation's primary business?

Ingevity Corporation is in the CHEMICALS & ALLIED PRODUCTS industry, SIC code 2800.

Where is Ingevity Corporation headquartered?

Ingevity Corporation's business and mail address is 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON, SC 29405.

Filing Stats: 783 words · 3 min read · ~3 pages · Grade level 12.7 · Accepted 2024-07-01 06:44:42

Key Financial Figures

Filing Documents

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ MARY DEAN HALL Mary Dean Hall Executive Vice President and Chief Financial Officer Date: July 1, 2024

View on Read The Filing